OTC Valuations Research Report »
On 05 Sep 2008 in A-Team Delivery Terms, A-Team Free, A-Team Free Access, OTC Valuations, Research 
Introducing a major new research report from A-Team Group…
OTC Valuations: Pricing Assets in the Post Credit Crunch World
A-Team’s OTC Valuations research report is the industry’s only guide to the complex business of valuing assets.
The industry is reaching a perfect storm of circumstances that are ensuring valuations become an essential part of every financial institution’s plans and more importantly, budgets! The scale of the credit crunch, the resultant regulatory scrutiny being focused on financial institutions, and their renewed focus on proactive risk management, are all coming at a time when OTC instruments have become ever more complex and therefore more difficult to price.
Demystifying the valuations business, A-Team Group’s PDF-based report, produced in partnership with industry expert Ian Blance, delivers:
- An analysis of the key methods and issues surrounding valuations approaches, including pros and cons of each method.
- A review of the impact that various regulatory and accounting initiatives will have on valuations practices.
- A comprehensive review of current industry practices and direction in which the business is headed, based on an in-depth survey conducted by A-Team Group, of decision makers across buy and sell side firms involved in OTC product valuations strategy. How are users approaching the sourcing of valuations? How do they rate suppliers of data across asset types? What level of budget is being spent on valuations? And more.
- An independent overview of each of the Tier 1, 2 and 3 data suppliers and specialists producing third party valuations.
Who Should Read It?
Essential reading for anyone involved in valuations to understand what your peers and competitors are doing to meet the changing requirements:
- Valuations professionals at buy and sell-side institutions and custodians
- Chief information officers
- Heads of reference data
- Heads of market data
- Heads of operations
- Heads of compliance
- Heads of risk management
- CEOs, head of sales, head of marketing at valuations data suppliers and software providers
- Regulators, financial accountants and auditors
How to Purchase
The report is available for a one-off purchase at £1,200 or $2,280.
Or you can purchase a full Annual Valuations Package at £1,850 or $3,515, which includes:
- A copy of the OTC Valuations report
- Four quarterly briefing updates covering key industry developments impacting on OTC valuations, such as FAS 157
- Directory of vendor profiles covering in-depth strategy, product profiles and more on Tier 3 vendors.
Want to Find Out More?
Download our table of contents and introduction free of charge to see if it’s right for you. See the bottom of this page to download the free TOC.
For more information, contact:
Director of Sales
Martyn Hodges
Tel: +44 (0)20 7096 8444
martyn.hodges@a-teamgroup.com